Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 17

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 17
---
 the event that (a) the Investor is the holder of any Depositary Shares on the VWAP Purchase Date that were the subject of a VWAP Purchase
Notice for such VWAP Purchase Date and (b) if within three (3) Business Days following a VWAP Purchase Date, the Company issues or sells
any Depositary Shares or Ordinary Share Equivalents (calculated on an as converted, as exercised basis), in each case other than pursuant
to an Exempt Issuance, pursuant to which Depositary Shares may be acquired at a New Issuance Price, then at the option of the Investor,
the VWAP Purchase Price related to that subject VWAP Purchase Notice may be reduced to the New Issuance Price, subject to
hereof.

(rr) “” means, with respect to a VWAP Purchase made pursuant to hereof, the number of Purchase Shares
directed by the Company to be purchased by the Investor in a VWAP Purchase Notice, which number of Purchase Shares shall not exceed $2,500,000
of Purchase Shares.

(ss) “” means, with respect to a VWAP Purchase made pursuant to hereof, thirty percent (30%).

(tt) “” means, with respect to a VWAP Purchase made pursuant to hereof, a number of Depositary
Shares equal to (i) the number of Purchase Shares specified by the Company in the applicable VWAP Purchase Notice as the VWAP Purchase
Share Amount to be purchased by the Investor in such VWAP Purchase, divided by (ii) the VWAP Purchase Share Percentage (to be appropriately
adjusted for any reorganization, recapitalization, non-cash dividend, share split, reverse share split, Depositary Share-Ordinary Share
ratio change or other similar transaction).

2. PURCHASE OF DEPOSITARY SHARES.

Subject to the terms and conditions
set forth in this Agreement, the Company has the right, but not the obligation, to sell to the Investor, in the Company’s sole and
absolute discretion, and the Investor has the obligation to purchase from the Company, Purchase Shares as follows:

| -7- |

(a) . Upon the satisfaction of all of the conditions set forth in and hereof
(the “” and the date of satisfaction of such conditions the “”) and
thereafter, until the Maturity Date or as earlier terminated in accordance with the terms of this Agreement, the Company shall have the
right, but not the obligation, to direct the Investor, by its delivery to the